Antibody recognizing N-domain of midkine
US9624294B2 · kind B2 · utility
0Cited by
13References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2012 |
| Grant date | Apr 18, 2017 |
| Priority date | — |
| Expiry date | Dec 23, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to isolated or recombinant proteins, such as antibodies, which inhibit or reduce the function of midkine (hereinafter, referred to as “MK”) for use in the treatment or prevention of midkine-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.